Nivolumab and Ipilimumab in Classical Kaposi Sarcoma (CKS)

Clinical trial NCT03219671 · UNKNOWN

Trial details

NCT number: NCT03219671
Sponsor: Alona Zer
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Classic Kaposi Sarcoma

Start date: 2018-04-01
Primary completion: 2020-09-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.